{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:15:51Z","timestamp":1791270951439,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21NS106490"],"award-info":[{"award-number":["R21NS106490"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R25GM064120"],"award-info":[{"award-number":["R25GM064120"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 GM008396"],"award-info":[{"award-number":["T32 GM008396"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bbrc.2020.07.031","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T00:45:16Z","timestamp":1596069916000},"page":"107-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["AAV9-DOK7 gene therapy reduces disease severity in Smn2B\/- SMA model mice"],"prefix":"10.1016","volume":"530","author":[{"given":"Kevin A.","family":"Kaifer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2068-4094","authenticated-orcid":false,"given":"Eric","family":"Villal\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1861-2710","authenticated-orcid":false,"given":"Caley E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline E.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Marquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail E.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7729-070X","authenticated-orcid":false,"given":"Toni I.","family":"Morcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1023-2169","authenticated-orcid":false,"given":"Christian L.","family":"Lorson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2020.07.031_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ejhg.2011.134","article-title":"Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens","volume":"20","author":"Sugarman","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2020.07.031_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/nbdi.1996.0010","article-title":"The neurobiology of childhood spinal muscular atrophy","volume":"3","author":"Crawford","year":"1996","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2020.07.031_bib3","first-page":"546","article-title":"SMN in spinal muscular atrophy and snRNP biogenesis","volume":"2","author":"Coady","year":"2011","journal-title":"Adv. Rev."},{"key":"10.1016\/j.bbrc.2020.07.031_bib4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainres.2012.01.044","article-title":"Spinal muscular atrophy: the role of SMN in axonal mRNA regulation","volume":"1462","author":"Fallini","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.bbrc.2020.07.031_bib5","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s40263-018-0545-1","article-title":"Nusinersen: a review in 5q spinal muscular atrophy","volume":"32","author":"Hoy","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bbrc.2020.07.031_bib6","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1172\/JCI121658","article-title":"Two breakthrough gene-targeted treatments for spinal muscular atrophy: challenges remain","volume":"128","author":"Sumner","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2020.07.031_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3390\/ph3020345","article-title":"Olesoxime (TRO19622): a novel mitochondrial-targeted neuroprotective compound","volume":"3","author":"Bordet","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbrc.2020.07.031_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1124\/jpet.114.222224","article-title":"The small-molecule fast skeletal troponin activator, CK-2127107, improves exercise tolerance in a rat model of heart failure","volume":"353","author":"Hwee","year":"2015","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbrc.2020.07.031_bib9","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1523\/JNEUROSCI.4434-08.2009","article-title":"Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice","volume":"29","author":"Kong","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2020.07.031_bib10","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1093\/hmg\/ddn156","article-title":"Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy","volume":"17","author":"Kariya","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2020.07.031_bib11","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/hmg\/ddm367","article-title":"Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy","volume":"17","author":"Murray","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2020.07.031_bib12","doi-asserted-by":"crossref","first-page":"11088","DOI":"10.1073\/pnas.0504806102","article-title":"Agrin promotes synaptic differentiation by counteracting an inhibitory effect of neurotransmitter","volume":"102","author":"Misgeld","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2020.07.031_bib13","doi-asserted-by":"crossref","first-page":"19348","DOI":"10.1073\/pnas.1319280110","article-title":"Dysregulation of synaptogenesis genes antecedes motor neuron pathology in spinal muscular atrophy","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2020.07.031_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0896-6273(00)80751-5","article-title":"Alternatively spliced isoforms of nerve- and muscle-derived agrin: their roles at the neuromuscular junction","volume":"23","author":"Burgess","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2020.07.031_bib15","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1093\/hmg\/ddx124","article-title":"Motor neuronal repletion of the NMJ organizer, Agrin, modulates the severity of the spinal muscular atrophy disease phenotype in model mice","volume":"26","author":"Kim","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2020.07.031_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fncel.2018.00017","article-title":"Increasing agrin function antagonizes muscle atrophy and motor impairment in spinal muscular atrophy","volume":"12","author":"Boido","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbrc.2020.07.031_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev-physiol-022516-034255","article-title":"Neuromuscular junction formation, aging, and disorders","volume":"80","author":"Li","year":"2018","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bbrc.2020.07.031_bib18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1128\/MCB.00775-15","article-title":"Sorbs1 and -2 interact with CrkL and are required for acetylcholine receptor cluster formation","volume":"36","author":"Hallock","year":"2016","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2020.07.031_bib19","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1101\/gad.1977710","article-title":"Dok-7 regulates neuromuscular synapse formation by recruiting Crk and Crk-L","volume":"24","author":"Hallock","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrc.2020.07.031_bib20","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1126\/science.1250744","article-title":"Neuromuscular disease. DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction","volume":"345","author":"Arimura","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2020.07.031_bib21","doi-asserted-by":"crossref","first-page":"880","DOI":"10.15252\/emmm.201607298","article-title":"DOK7 gene therapy enhances motor activity and life span in ALS model mice","volume":"9","author":"Miyoshi","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbrc.2020.07.031_bib22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.molcel.2010.06.007","article-title":"The cytoplasmic adaptor protein Dok7 activates the receptor tyrosine kinase MuSK via dimerization","volume":"39","author":"Bergamin","year":"2010","journal-title":"Mol. Cell."},{"key":"10.1016\/j.bbrc.2020.07.031_bib23","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1126\/science.1127142","article-title":"The muscle protein Dok-7 is essential for neuromuscular synaptogenesis","volume":"312","author":"Okada","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2020.07.031_bib24","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1126\/science.1130837","article-title":"Dok-7 mutations underlie a neuromuscular junction synaptopathy","volume":"313","author":"Beeson","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2020.07.031_bib25","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/brain\/awm068","article-title":"Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes","volume":"130","author":"Muller","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.bbrc.2020.07.031_bib26","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/brain\/awm072","article-title":"Clinical features of the DOK7 neuromuscular junction synaptopathy","volume":"130","author":"Palace","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.bbrc.2020.07.031_bib27","doi-asserted-by":"crossref","first-page":"ra7","DOI":"10.1126\/scisignal.2000113","article-title":"Dok-7 activates the muscle receptor kinase MuSK and shapes synapse formation","volume":"2","author":"Inoue","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbrc.2020.07.031_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89970","article-title":"Plastin-3 extends survival and reduces severity in mouse models of spinal muscular atrophy","volume":"2","author":"Kaifer","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbrc.2020.07.031_bib29","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ajhg.2016.07.014","article-title":"The power of human protective modifiers: PLS3 and CORO1C unravel impaired endocytosis in spinal muscular atrophy and rescue SMA phenotype","volume":"99","author":"Hosseinibarkooie","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2020.07.031_bib30","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/hmg\/ddv629","article-title":"Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onset","volume":"25","author":"Feng","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2020.07.031_bib31","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1093\/hmg\/ddz188","article-title":"AAV9-Stathmin1 gene delivery improves disease phenotype in an intermediate mouse model of spinal muscular atrophy","volume":"28","author":"Villalon","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2020.07.031_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ajhg.2019.05.008","article-title":"NCALD antisense oligonucleotide therapy in addition to Nusinersen further ameliorates spinal muscular atrophy in mice","volume":"105","author":"Torres-Benito","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2020.07.031_bib33","doi-asserted-by":"crossref","first-page":"7799","DOI":"10.1038\/s41598-019-44222-2","article-title":"Nerve sprouting capacity in a pharmacologically induced mouse model of spinal muscular atrophy","volume":"9","author":"Rimer","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2020.07.031_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203398","article-title":"Evaluation of potential effects of Plastin 3 overexpression and low-dose SMN-antisense oligonucleotides on putative biomarkers in spinal muscular atrophy mice","volume":"13","author":"Strathmann","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.bbrc.2020.07.031_bib35","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1093\/brain\/awy167","article-title":"CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis","volume":"141","author":"Janzen","year":"2018","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.bbrc.2020.07.031_bib36","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1242\/dmm.030148","article-title":"Therapeutic strategies for spinal muscular atrophy: SMN and beyond","volume":"10","author":"Bowerman","year":"2017","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.bbrc.2020.07.031_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddw278","article-title":"Effect of genetic background on the phenotype of theSmn2B\/-mouse model of spinal muscular atrophy","author":"Eshraghi","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2020.07.031_bib38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1741-7015-10-24","article-title":"Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy","volume":"10","author":"Bowerman","year":"2012","journal-title":"BMC Med."},{"key":"10.1016\/j.bbrc.2020.07.031_bib39","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.yjmcc.2012.01.005","article-title":"Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy","volume":"52","author":"Shababi","year":"2012","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbrc.2020.07.031_bib40","doi-asserted-by":"crossref","first-page":"e89970","DOI":"10.1172\/jci.insight.89970","article-title":"Plastin-3 extends survival and reduces severity in mouse models of spinal muscular atrophy","volume":"2","author":"Kaifer","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbrc.2020.07.031_bib41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/path.4080","article-title":"Synaptic defects in type I spinal muscular atrophy in human development","volume":"229","author":"Martinez-Hernandez","year":"2013","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.bbrc.2020.07.031_bib42","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/hmg\/ddn426","article-title":"Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy","volume":"18","author":"Rose","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2020.07.031_bib43","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/jcsm.12542","article-title":"Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy","volume":"11","author":"Zhou","year":"2020","journal-title":"J.\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.bbrc.2020.07.031_bib44","doi-asserted-by":"crossref","first-page":"12063","DOI":"10.1523\/JNEUROSCI.0608-15.2015","article-title":"IGF-1R reduction triggers neuroprotective signaling pathways in spinal muscular atrophy mice","volume":"35","author":"Biondi","year":"2015","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2020.07.031_bib45","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddu169","article-title":"Defining the therapeutic window in a severe animal model of spinal muscular atrophy","author":"Robbins","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2020.07.031_bib46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbrc.2020.07.031_bib47","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2020.07.031_bib48","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/14789450.2017.1345631","article-title":"Advances in understanding the role of disease-associated proteins in spinal muscular atrophy","volume":"14","author":"Hosseinibarkooie","year":"2017","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.bbrc.2020.07.031_bib49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jviromet.2006.06.011","article-title":"Quantitation of encapsidated recombinant adeno-associated virus DNA in crude cell lysates and tissue culture medium by quantitative, real-time PCR","volume":"137","author":"Mayginnes","year":"2006","journal-title":"J.\u00a0Virol Methods"},{"key":"10.1016\/j.bbrc.2020.07.031_bib50","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddz142","article-title":"AAV9-Mediated delivery of miR-23a reduces disease severity in Smn2B-\/SMA model mice","author":"Kaifer","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2020.07.031_bib51","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1093\/hmg\/ddz142","article-title":"AAV9-mediated delivery of miR-23a reduces disease severity in Smn2B\/-SMA model mice","volume":"28","author":"Kaifer","year":"2019","journal-title":"Hum. Mol. Genet."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20314182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20314182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:27:30Z","timestamp":1784910450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X20314182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0006291X20314182"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.07.031","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAV9-DOK7 gene therapy reduces disease severity in Smn2B\/- SMA model mice","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.07.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}